Related references
Note: Only part of the references are listed.Transcriptome-directed analysis for Mendelian disease diagnosis overcomes limitations of conventional genomic testing
David R. Murdock et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Detection of aberrant splicing events in RNA-seq data using FRASER
Christian Mertes et al.
NATURE COMMUNICATIONS (2021)
Diagnostic utility of transcriptome sequencing for rare Mendelian diseases
Hane Lee et al.
GENETICS IN MEDICINE (2020)
Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes
Tyler Landrith et al.
NPJ PRECISION ONCOLOGY (2020)
The functional impact of variants of uncertain significance in BRCA2
Romy L. S. Mesman et al.
GENETICS IN MEDICINE (2019)
Incorporation of semi-quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 and BRCA2 genes
Gemma Montalban et al.
HUMAN MUTATION (2019)
Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts
Laure Fresard et al.
NATURE MEDICINE (2019)
Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes
Rita D. Brandao et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Screening of BRCA1/2 deep intronic regions by targeted gene sequencing identifies the first germline BRCA1 variant causing pseudoexon activation in a patient with breast/ovarian cancer
Gemma Montalban et al.
JOURNAL OF MEDICAL GENETICS (2019)
Characterization of spliceogenic variants located in regions linked to high levels of alternative splicing: BRCA2 c.7976+5G>T as a case study
Gemma Montalban et al.
HUMAN MUTATION (2018)
Full in-frame exon 3 skipping of brca2 confers high risk of breast and/or ovarian cancer
Sandrine M. Caputo et al.
Oncotarget (2018)
Investigation of Experimental Factors That Underlie BRCA1/2 mRNA Isoform Expression Variation: Recommendations for Utilizing Targeted RNA Sequencing to Evaluate Potential Spliceogenic Variants
Vanessa L. Lattimore et al.
FRONTIERS IN ONCOLOGY (2018)
Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices
Amanda Ewart Toland et al.
NPJ GENOMIC MEDICINE (2018)
A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
D. Gareth R. Evans et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
Elizabeth Santana dos Santos et al.
CANCERS (2018)
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer
Angela George et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer
Gregoire Davy et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2017)
Improving genetic diagnosis in Mendelian disease with transcriptome sequencing
Beryl B. Cummings et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Genetic diagnosis of Mendelian disorders via RNA sequencing
Laura S. Kremer et al.
NATURE COMMUNICATIONS (2017)
Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events
Lucy C. de Jong et al.
BREAST CANCER RESEARCH (2017)
Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing
Helen Byers et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples
James D. Fackenthal et al.
JOURNAL OF MEDICAL GENETICS (2016)
RNAseq analysis for the diagnosis of muscular dystrophy
Hernan Gonorazky et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations
Gaetana Gambino et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Comparison of mRNA Splicing Assay Protocols across Multiple Laboratories: Recommendations for Best Practice in Standardized Clinical Testing
Phillip J. Whiley et al.
CLINICAL CHEMISTRY (2014)
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium
Mara Colombo et al.
HUMAN MOLECULAR GENETICS (2014)
Capillary Electrophoresis Analysis of Conventional Splicing Assays: IARC Analytical and Clinical Classification of 31 BRCA2 Genetic Variants
Gorka Ruiz de Garibay et al.
HUMAN MUTATION (2014)
Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention
Fergus J. Couch et al.
SCIENCE (2014)
BRCA2 Deep Intronic Mutation Causing Activation of a Cryptic Exon: Opening toward a New Preventive Therapeutic Strategy
Olga Anczukow et al.
CLINICAL CANCER RESEARCH (2012)
An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition
Daniele Muller et al.
BMC MEDICAL GENETICS (2011)
Allelic Imbalance in BRCA1 and BRCA2 Gene Expression and Familial Ovarian Cancer
Jie Shen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal
Ana Peixoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
Genetic Predisposition to Breast Cancer: Past, Present, and Future
Clare Turnbull et al.
Annual Review of Genomics and Human Genetics (2008)
Alternatively spliced, truncated human BRCA2 isoforms contain a novel coding exon
MD Speevak et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2003)
Share Paper
